For the Quarter Ending December 2022
North America
The Doxycycline Hydrochloride market showcased mixed sentiments during the fourth quarter of 2022 in the North American region. The Doxycycline Hydrochloride prices in the United States inclined till November and resumed their downward momentum in December. The reason behind an overall increase of 3.8% till November was surging demand from the downstream pharmaceutical and healthcare industries amidst high purchasing activities and limited inventories. By the termination of the fourth quarter, Doxycycline Hydrochloride prices declined by 4.1% owing to low offtakes for the product from regional buyers considering the weak demand. The CFR prices for Doxycycline Hydrochloride were assessed at USD 83550/MT in the United States at the end of the quarter.
Asia- Pacific
During the final quarter of 2022, the Doxycycline Hydrochloride market showcased an overall fluctuating pricing trend in the Asia-Pacific region. In the Chinese market, the prices dropped considerably with the onset of Q4 due to enough inventories with the local vendor amidst slow offtakes from downstream producers. However, the demand in mid-Q4 went on the higher side with lower stocks. Some production activities decreased owing to the lockdown in Shanghai with rising COVID cases, propelling the manufacturers to increase their rates to gain profits considering low inventories. Therefore, the Lopinavir API market dynamics got stable on the lower side over the end of Q4 in China, with FOB Shanghai prices settling at USD 66255/MT.
Europe
In Europe, the prices of Doxycycline Hydrochloride fluctuated during the Q4 of FY2022, resembling the North American market price trend. The primary reason for these fluctuations was the constant alteration of supply and demand dynamics. Additionally, fluctuations in trade frequency from China during the whole quarter also affected the market value of Doxycycline Hydrochloride. The slow offtake from downstream pharmaceuticals and healthcare industries was one of the factors behind this flutter price trend of Doxycycline Hydrochloride. Also, the inventories among domestic merchants hovered, which also influenced the mixed market sentiments of Doxycycline Hydrochloride in Europe. Thus, the CFR prices of Doxycycline Hydrochloride in Germany settled at USD 88860/MT in December.
For the Quarter Ending September 2022
North America
The third quarter of 2022 started positively for the North American Doxycycline Hydrochloride market, with prices settling at USD 85320/MT in July. Lack of inventory and high demand for the product from the downstream pharmaceutical industry were the reasons behind the spike. Many Chinese API production facilities were shut down for maintenance during the last week of July, significantly reducing imports into the US. However, these values eventually decreased from the second half of the quarter and were assembled at USD 83890/MT in September. Demand from the downstream sector declined during H2 as downstream entities were in a solid wait-and-see attitude, forcing US suppliers to cut their prices to increase orders.
Asia- Pacific
In the third quarter of 2022, the price trend for Doxycycline Hydrochloride in the Asia Pacific market exhibited a seesaw trajectory. The market opened with favorable sentiments in the first half of Q3, and prices eventually settled at USD 77376/MT in July. As some facilities underwent maintenance and others reduced their production because of the high temperatures, the market ran low on supplies. The producer did, however, experience a significant demand-supply imbalance in the market, which led to an increase in Doxycycline Hydrochloride prices in August. However, when plants started to resume production at the beginning of September due to a drop in temperature, the uptrend subsequently declined in September and was assembled at USD 71445/MT. Consequently, the market's supply returned to normal, and demand from the downstream pharmaceutical sector continued to be consistent.
Europe
The market fundamentals for Doxycycline Hydrochloride in Europe were comparable to those in North America in the Q3 of 2022. However, CFR prices tended to rise to USD 92810/MT in the first half of the quarter due to a shortage of product inventories in the German domestic market. Later in the second half, prices dropped, and by the end of September had reached USD 88070/MT. Domestic merchants were forced to cut their costs due to the product's sluggish demand from end-user pharmaceutical industries. However, China's reduced price quotes as a result of resuming manufacturing operations during the second half of the quarter were also the cause of the downward trend in Europe.
North America
In the North American region, Doxycycline Hydrochloride witnessed a negative market sentiment during the second quarter of 2022 due to ample supplies, and domestic buyers were relatively quiet this quarter. Despite the Shanghai shutdown and other Covid-related economic barriers in China, after seasonal adjustment in April, US imports from China surged to an all-time high, significantly affecting the US market of Doxycycline Hydrochloride. Suppliers were able to meet demand on the supply side because they had plenty of inventory on hand. Still, demand-wise, offtakes from the end-user pharmaceutical and nutraceutical industries held steady throughout the quarter. In the United States, the CFR prices of Doxycycline Hydrochloride dropped by 11.6% this quarter with values settled at USD 82040/MT.
Asia- Pacific
The market trend for Doxycycline Hydrochloride exhibited a negative path in the second quarter of 2022. Participants in the sector claimed that demand in the downstream pharmaceutical and nutraceutical sectors remained weaker than expected. China is the world's largest producer of Doxycycline Hydrochloride; its trade restriction has significantly impacted commerce with importing nations. It seems clear that the delays off the coast will take a bit longer to overcome, given the repeated predictions for bottleneck relief with little progress. Manufacturing and logistics are stifled by China's "ineffective" zero-tolerance rules and limitations. In China, the FOB Shanghai prices of Doxycycline Hydrochloride sharply declined by more than 25% this quarter with values settled at USD 60555/MT.
Europe
Doxycycline Hydrochloride prices in the European market have declined since April, supported by abundant inventories and shaky demand. In addition, Doxycycline Hydrochloride prices decreased with subdued market sentiment due to the reduced production cost of raw material Terramycin during the second quarter of 2022. Additionally, the market fundamentals have also been hindered by a decline in demand from the downstream pharmaceutical and nutraceutical sectors resulting in a plunge in prices in the German market. Furthermore, in terms of inventories, slowing demand impacted the market dynamics with rising stocks of Doxycycline Hydrochloride. In Germany, the CFR prices of Doxycycline Hydrochloride scaled down to 10.7% in this quarter with values settled at USD 86800/MT.
